InMed Pharmaceuticals Inc. - INM

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2024 · Q1 2024
Value (USD)
Total reported value ($000)
$7K
QoQ value delta ($000)
-$104K (-93.69%)
Implied price effect (QoQ)
-35.94%
Shares
Total shares
30,366
QoQ shares delta
-278,073 (-90.15%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (INM)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2024)

Top 25 only Full list
Early Q2 2026 data: only 20 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
XTX Topco Ltd 4 17,819 0.0%
CITADEL ADVISORS LLC 3 12,097 0.0%
BANK OF AMERICA CORP /DE/ 0 100 0.0%
TORONTO DOMINION BANK 0 2 0.0%
ROYAL BANK OF CANADA 0 25 0.0%
OSAIC HOLDINGS, INC. 0 32 0.0%
Qube Research & Technologies Ltd 0 200 0.0%
Global Retirement Partners, LLC 0 6 0.0%
TD Waterhouse Canada Inc. 0 85 0.0%